Pharma IQ Members

Infographic: Clinical VS Commercial Temperature Controlled Supply Chains in Canada

pharma
Posted: 12/21/2016

According to the BMI healthcare report, Canada’s pharmaceutical sales are forecasted to leap to US$22.730bn by the year 2020. This is up from 2015’s US$19.6bn.1 Canada has been ranked in the top 10 of cold chain export markets in a recent industry report.2 Challenges such as country  pecific regulations, non-tariff barriers and clearing customs stand as hurdles for both cold chains transporting pharma products both pre and post market approval. With biologics filling a vast amount R&D pipelines successful temperature control during transit is at the forefront of many strategies. 

With the strength of this region in mind, Pharma Logistics IQ surveyed its network to pinpoint trends within Canada’s clinical and commercial temperature controlled supply chains. 

                          INfo

Interested in learning more about this topic?
Canada
Download The Brochure for the Cold chain GDP Temperature Management Logistics Summit Canada 2017 Here

Join us in Toronto to network with industry peers, benchmark your processes against leaders in the space, and bring back innovative ideas to implement within your teams immediately. We will be covering key concerns from regulatory, logistics, quality, packaging, security, & overall supply chain management, and hitting on all challenges unique to the Canadian market while still maintaining a global focus

Download the infographic below.

Have Your Say
Rate this feature and give us your feedback in the comments section below
To continue viewing this content please fill out the form below and become an Cold Chain IQ member.
Or if you're already a Cold Chain IQ member, sign in below to download.
Subscribe

By entering in your information and submitting the form, you give the sponsor permission to contact you regarding their product and you agree to our User Agreement, Privacy Policy, and Cookie Policy.

pharma
Posted: 12/21/2016